DRRX

DRRX

USD

DURECT Corporation Common Stock

$0.660+0.062 (10.392%)

Preço em tempo real

Healthcare
Drug Manufacturers - Specialty & Generic
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$0.598

Máximo

$0.680

Mínimo

$0.598

Volume

0.06M

Fundamentos da empresa

Capitalização de mercado

20.5M

Setor

Drug Manufacturers - Specialty & Generic

País

United States

Estatísticas de negociação

Volume médio

0.11M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $0.48Atual $0.660Máximo $1.84

Notícias relacionadas

Analyst Upgrades

HC Wainwright & Co. Reiterates Neutral on Durectto Neutral

HC Wainwright & Co. analyst Ed Arce reiterates Durect from Neutral to Neutral.

Ver mais
HC Wainwright & Co. Reiterates Neutral on Durectto Neutral
PR Newswire

DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

DURECT Corporation (Nasdaq: DRRX) today announced financial results for the fourth quarter and full year ended December 31, 2024 and provided a...

Ver mais
DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
PR Newswire

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated ...

Ver mais
DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update